دورية أكاديمية
РЕТРОСПЕКТИВНО ГНЕЗДОВО ПРОУЧВАНЕ НА ДЕМОГРАФСКИТЕ ХАРАКТЕРИСТИКИ, ЛЕТАЛИТЕТА И ИЗПИСАНИТЕ ПАЦИЕНТИ, ХОСПИТАЛИЗИРАНИ С COVID-19, В ЦЕНТРАЛНА ЮЖНА БЪЛГАРИЯ
| العنوان: | РЕТРОСПЕКТИВНО ГНЕЗДОВО ПРОУЧВАНЕ НА ДЕМОГРАФСКИТЕ ХАРАКТЕРИСТИКИ, ЛЕТАЛИТЕТА И ИЗПИСАНИТЕ ПАЦИЕНТИ, ХОСПИТАЛИЗИРАНИ С COVID-19, В ЦЕНТРАЛНА ЮЖНА БЪЛГАРИЯ (Bulgarian) |
|---|---|
| Alternate Title: | RETROSPECTIVE NESTED STUDY OF DEMOGRAPHIC CHARACTERISTICS, LETHALITY AND DISCHARGE RATE OF COVID-19 INPATIENTS IN CENTRAL SOUTH OF BULGARIA. (English) |
| المؤلفون: | Джарова, Анита, Николова, Анелия, Гето-ва-Коларова, Виолета, Лебанова, Христина, Гетов, Илко |
| المصدر: | Bulgarian Journal of Public Health; 2023, Vol. 15 Issue 1, p38-44, 7p |
| مصطلحات موضوعية: | COVID-19, HOSPITAL patients, MEDICAL records, DEATH rate, DEMOGRAPHIC characteristics |
| مصطلحات جغرافية: | BULGARIA |
| الشركة/الكيان: | EUROPEAN Union |
| مستخلص: | Introduction: SARS-CoV-2 infection has affected more than 683 million people worldwide with 6.8 million deaths. Unfortunately, Bulgaria is one of the most severely affected European Union (EU) member-states with one of the highest mortality rates. Lim: The study aims to provide a description of the demographic characteristics, discharge rate, and fatality rate of COVID-19-diagnosed patients in one region of Central South Bulgaria in 2021. Materials and methods: A retrospective nested case series study was conducted among patients hospitalized with a confirmed diagnosis of SARS-CoV-2 infection between January 1st and December 31st, 2021. Anonymized patient data on age, sex, admission and discharge dates, treatment, and the outcome was collected from hospital electronic patient records and analyzed using descriptive statistics. Results: Data from 1630 (51% male) patients were identified. The mean age was 63.64 years (±15.23). 1342 (82%) of the patients were discharged. The mean age of the diseased was 70.88 years (±10.05). 1455 (89%) patients received only symptomatic therapy, 155 (10%) patients were treated with remdesivir (Veklury®), 11 (1%) patients were treated with casirivimab/imdevimab (Ronapreve®) and 9 (1%) patients were administered regdanvimab (Regkirona®). Conclusions: The study results demonstrate that Bulgarian patients with COVID-19 were treated according to the best global and national evidencebased guidelines. Lethality and discharge rates are in concordance with global trends and outcomes. [ABSTRACT FROM AUTHOR] |
| Copyright of Bulgarian Journal of Public Health is the property of National Center of Public Health & Analyses and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| قاعدة البيانات: | Complementary Index |
كن أول من يترك تعليقا!